The targeted inhibitory effects of human amniotic fluid stem cells carrying CXCR4 promoter and DAL-1 on non-small cell lung carcinoma growth.

about

An update clinical application of amniotic fluid-derived stem cells (AFSCs) in cancer cell therapy and tissue engineering.Targeted silencing of SOX2 by an artificial transcription factor showed antitumor effect in lung and esophageal squamous cell carcinoma.

P2860

Q38967733-167AB068-5B77-43BC-88D7-308D241D2A3F Q47102677-E0AEA2F8-9DDD-46E8-B4C9-5EE9FC008345

P2860

The targeted inhibitory effects of human amniotic fluid stem cells carrying CXCR4 promoter and DAL-1 on non-small cell lung carcinoma growth.

Item

http://www.wikidata.org/entity/Q41048929

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

The targeted inhibitory effect ...... ll cell lung carcinoma growth.

@en

type

Item

label

The targeted inhibitory effect ...... ll cell lung carcinoma growth.

@en

prefLabel

The targeted inhibitory effect ...... ll cell lung carcinoma growth.

@en

P1476

The targeted inhibitory effect ...... ll cell lung carcinoma growth.

@en

P2093

H Wang

http://www.w3.org/2001/XMLSchema#string

L Li

http://www.w3.org/2001/XMLSchema#string

S Li

http://www.w3.org/2001/XMLSchema#string

T Cai

http://www.w3.org/2001/XMLSchema#string

X Xie

http://www.w3.org/2001/XMLSchema#string

Y Zhang

http://www.w3.org/2001/XMLSchema#string

Z Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Mesenchymal stem cells migration homing and tracking

The potential of mesenchymal stem cells derived from amniotic membrane and amniotic fluid for neuronal regenerative therapy.

Cancer statistics, 2013

Immunolocalization of protein 4.1B in the rat digestive system

Replication-selective adenoviruses as oncolytic agents.

Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application.

The oncolytic virotherapy treatment platform for cancer: unique biological and biosafety points to consider.

HCCS1-armed, quadruple-regulated oncolytic adenovirus specific for liver cancer as a cancer targeting gene-viro-therapy strategy.

P-glycoprotein-based loperamide-cyclosporine drug interaction at the rat blood-brain barrier: prediction from in vitro studies and extrapolation to humans.

Generation of a novel, cyclooxygenase-2-targeted, interferon-expressing, conditionally replicative adenovirus for pancreatic cancer therapy.

P2888

gt.2015.90

P304

214-222

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/GT.2015.90

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1033708925

http://www.w3.org/2001/XMLSchema#string

P698

26280082

http://www.w3.org/2001/XMLSchema#string

The targeted inhibitory effects of human amniotic fluid stem cells carrying CXCR4 promoter and DAL-1 on non-small cell lung carcinoma growth.

about

P2860

P2860

The targeted inhibitory effects of human amniotic fluid stem cells carrying CXCR4 promoter and DAL-1 on non-small cell lung carcinoma growth.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698